Insufficient scRNA-seq data for expression of VPS33A at single-cell level.
Insufficient scRNA-seq data for expression of VPS33A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1329.14 | 1445 / 1445 | 100% | 6.03 | 183 / 183 |
bladder | 100% | 1460.57 | 21 / 21 | 100% | 7.12 | 503 / 504 |
prostate | 100% | 1194.92 | 245 / 245 | 100% | 5.75 | 501 / 502 |
uterus | 100% | 1412.34 | 170 / 170 | 100% | 7.04 | 458 / 459 |
brain | 100% | 1416.75 | 2636 / 2642 | 100% | 9.80 | 705 / 705 |
breast | 100% | 1246.83 | 459 / 459 | 100% | 7.97 | 1115 / 1118 |
adrenal gland | 100% | 1743.03 | 258 / 258 | 100% | 14.28 | 229 / 230 |
ovary | 100% | 1162.44 | 180 / 180 | 100% | 7.20 | 428 / 430 |
thymus | 100% | 1083.70 | 652 / 653 | 100% | 7.28 | 602 / 605 |
stomach | 100% | 1150.38 | 359 / 359 | 99% | 6.54 | 284 / 286 |
skin | 100% | 1551.76 | 1809 / 1809 | 99% | 8.69 | 468 / 472 |
intestine | 100% | 1519.15 | 966 / 966 | 99% | 6.52 | 522 / 527 |
liver | 100% | 799.94 | 226 / 226 | 99% | 6.24 | 402 / 406 |
kidney | 100% | 998.38 | 89 / 89 | 99% | 6.22 | 892 / 901 |
lung | 97% | 1049.77 | 563 / 578 | 100% | 6.51 | 1154 / 1155 |
pancreas | 97% | 713.81 | 319 / 328 | 98% | 5.54 | 175 / 178 |
adipose | 100% | 1280.23 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 11.31 | 29 / 29 |
spleen | 100% | 1842.33 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 6.46 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.14 | 1 / 1 |
muscle | 100% | 1510.23 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1300.46 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 1301.62 | 899 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 5.72 | 77 / 80 |
heart | 95% | 720.06 | 819 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048070 | Biological process | regulation of developmental pigmentation |
GO_0032400 | Biological process | melanosome localization |
GO_0006886 | Biological process | intracellular protein transport |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0035751 | Biological process | regulation of lysosomal lumen pH |
GO_0008333 | Biological process | endosome to lysosome transport |
GO_0032418 | Biological process | lysosome localization |
GO_0035542 | Biological process | regulation of SNARE complex assembly |
GO_0097352 | Biological process | autophagosome maturation |
GO_0030220 | Biological process | platelet formation |
GO_0034058 | Biological process | endosomal vesicle fusion |
GO_0033263 | Cellular component | CORVET complex |
GO_0031902 | Cellular component | late endosome membrane |
GO_0030897 | Cellular component | HOPS complex |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005769 | Cellular component | early endosome |
GO_0005764 | Cellular component | lysosome |
GO_0030136 | Cellular component | clathrin-coated vesicle |
GO_0071439 | Cellular component | clathrin complex |
GO_0030123 | Cellular component | AP-3 adaptor complex |
GO_0005770 | Cellular component | late endosome |
GO_0005776 | Cellular component | autophagosome |
GO_0010008 | Cellular component | endosome membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | VPS33A |
Protein name | Vacuolar protein sorting-associated protein 33A Alternative protein VPS33A VPS33A core subunit of CORVET and HOPS complexes Vacuolar protein sorting-associated protein 33A (hVPS33A) |
Synonyms | |
Description | FUNCTION: Plays a role in vesicle-mediated protein trafficking to lysosomal compartments including the endocytic membrane transport and autophagic pathways. Believed to act as a core component of the putative HOPS and CORVET endosomal tethering complexes which are proposed to be involved in the Rab5-to-Rab7 endosome conversion probably implicating MON1A/B, and via binding SNAREs and SNARE complexes to mediate tethering and docking events during SNARE-mediated membrane fusion. The HOPS complex is proposed to be recruited to Rab7 on the late endosomal membrane and to regulate late endocytic, phagocytic and autophagic traffic towards lysosomes. The CORVET complex is proposed to function as a Rab5 effector to mediate early endosome fusion probably in specific endosome subpopulations . Required for fusion of endosomes and autophagosomes with lysosomes; the function is dependent on its association with VPS16 but not VIPAS39 . The function in autophagosome-lysosome fusion implicates STX17 but not UVRAG . . |
Accessions | ENST00000543633.5 A0A2R8Y5U3 ENST00000643696.1 F5H2X5 ENST00000451053.3 A0A2R8YF87 ENST00000267199.9 F5H7N5 ENST00000544349.6 ENST00000541169.1 L8EAC9 Q96AX1 F5H6Y0 ENST00000536212.2 A0A2R8Y5F6 |